Myovant Sciences Ltd. License Agreements
2 Contracts & Agreements
- Amendment No. 4 to License Agreement (Filed With SEC on May 11, 2022)
- Amendment No. 3 to License Agreement, dated December 15, 2020, by and between the Registrant and Takeda Pharmaceuticals International AG (Filed With SEC on February 11, 2021)
